JP2019507183A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019507183A5 JP2019507183A5 JP2018559164A JP2018559164A JP2019507183A5 JP 2019507183 A5 JP2019507183 A5 JP 2019507183A5 JP 2018559164 A JP2018559164 A JP 2018559164A JP 2018559164 A JP2018559164 A JP 2018559164A JP 2019507183 A5 JP2019507183 A5 JP 2019507183A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- variable domain
- amino acid
- acid sequence
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021047470A JP7140867B2 (ja) | 2016-01-29 | 2021-03-22 | Ｐｄ－ｌ１に結合する抗原結合性タンパク質 |
| JP2022067548A JP2022095910A (ja) | 2016-01-29 | 2022-04-15 | Ｐｄ－ｌ１に結合する抗原結合性タンパク質 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662288912P | 2016-01-29 | 2016-01-29 | |
| US62/288,912 | 2016-01-29 | ||
| PCT/US2017/015429 WO2017132562A1 (en) | 2016-01-29 | 2017-01-27 | Antigen binding proteins that bind pd-l1 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021047470A Division JP7140867B2 (ja) | 2016-01-29 | 2021-03-22 | Ｐｄ－ｌ１に結合する抗原結合性タンパク質 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019507183A JP2019507183A (ja) | 2019-03-14 |
| JP2019507183A5 true JP2019507183A5 (enExample) | 2019-12-26 |
| JP6883590B2 JP6883590B2 (ja) | 2021-06-09 |
Family
ID=59386438
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018559164A Active JP6883590B2 (ja) | 2016-01-29 | 2017-01-27 | Ｐｄ−ｌ１に結合する抗原結合性タンパク質 |
| JP2021047470A Active JP7140867B2 (ja) | 2016-01-29 | 2021-03-22 | Ｐｄ－ｌ１に結合する抗原結合性タンパク質 |
| JP2022067548A Pending JP2022095910A (ja) | 2016-01-29 | 2022-04-15 | Ｐｄ－ｌ１に結合する抗原結合性タンパク質 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021047470A Active JP7140867B2 (ja) | 2016-01-29 | 2021-03-22 | Ｐｄ－ｌ１に結合する抗原結合性タンパク質 |
| JP2022067548A Pending JP2022095910A (ja) | 2016-01-29 | 2022-04-15 | Ｐｄ－ｌ１に結合する抗原結合性タンパク質 |
Country Status (17)
| Country | Link |
|---|---|
| US (4) | US10118963B2 (enExample) |
| EP (1) | EP3408400B1 (enExample) |
| JP (3) | JP6883590B2 (enExample) |
| KR (1) | KR102927822B1 (enExample) |
| CN (2) | CN109715821B (enExample) |
| AU (1) | AU2017212717B2 (enExample) |
| BR (1) | BR112018015480A2 (enExample) |
| CA (1) | CA3013051A1 (enExample) |
| CL (1) | CL2018002034A1 (enExample) |
| EA (1) | EA037855B1 (enExample) |
| ES (1) | ES2986360T3 (enExample) |
| IL (1) | IL260846B2 (enExample) |
| MX (2) | MX2018009228A (enExample) |
| PH (1) | PH12018501611A1 (enExample) |
| SG (1) | SG11201806496SA (enExample) |
| TW (1) | TWI760323B (enExample) |
| WO (1) | WO2017132562A1 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104736168B (zh) | 2012-05-31 | 2018-09-21 | 索伦托治疗有限公司 | 与pd-l1结合的抗原结合蛋白 |
| GB201403775D0 (en) | 2014-03-04 | 2014-04-16 | Kymab Ltd | Antibodies, uses & methods |
| CA3013051A1 (en) | 2016-01-29 | 2017-08-03 | Heyue Zhou | Antigen binding proteins that bind pd-l1 |
| US9567399B1 (en) | 2016-06-20 | 2017-02-14 | Kymab Limited | Antibodies and immunocytokines |
| TWI640536B (zh) | 2016-06-20 | 2018-11-11 | 克馬伯有限公司 | 抗體 |
| US11779604B2 (en) | 2016-11-03 | 2023-10-10 | Kymab Limited | Antibodies, combinations comprising antibodies, biomarkers, uses and methods |
| KR20200135447A (ko) * | 2018-03-22 | 2020-12-02 | 카이레스 아게 | 길항성 pd-1, pd-l1 및 lag-3 결합 단백질 |
| US11993655B2 (en) | 2018-04-09 | 2024-05-28 | Oricell Therapeutics Co., Ltd. | Anti-PD-L1 antibody and use thereof |
| WO2019227490A1 (en) | 2018-06-01 | 2019-12-05 | Tayu Huaxia Biotech Medical Group Co., Ltd. | Compositions and methods for imaging |
| EP3818085A4 (en) * | 2018-06-01 | 2022-03-09 | Tayu Huaxia Biotech Medical Group Co., Ltd. | COMPOSITIONS AND THEIR USES FOR THE TREATMENT OF DISEASES OR DISORDERS |
| TW202016150A (zh) * | 2018-08-20 | 2020-05-01 | 大陸商北京強新生物科技有限公司 | 新穎癌症免疫治療抗體組合物 |
| EP3893902B1 (en) * | 2018-12-11 | 2024-10-23 | Sanford Burnham Prebys Medical Discovery Institute | Inhibitors of pd-l1 activity or expression for use in the treatment of serrated colorectal cancer |
| CN113795511B (zh) | 2019-01-23 | 2024-07-23 | 大有华夏生物医药集团有限公司 | 抗pd-l1双抗体及其用途 |
| EP3955925B1 (en) * | 2019-04-18 | 2026-02-11 | QLSF Biotherapeutics Inc. | Humanized anti-pd-l1 antibodies |
| CN113795510A (zh) | 2019-08-29 | 2021-12-14 | 荣昌生物制药(烟台)股份有限公司 | 抗pd-l1抗体及其应用 |
| US20230357793A1 (en) * | 2020-06-26 | 2023-11-09 | Sorrento Therapeutics, Inc. | Oncolytic herpes simplex viruses (hsv) expressing immunomodulatory fusion proteins |
| JP2023539369A (ja) | 2020-09-02 | 2023-09-13 | マヨ ファウンデーション フォー メディカル エデュケーション アンド リサーチ | 抗体－ナノ粒子複合体、ならびにその作製および使用方法 |
| EP4245865A4 (en) | 2020-11-16 | 2025-07-23 | Immuneoncia Therapeutics Inc | BIOMARKER FOR PREDICTING THERAPEUTIC RESPONSE TO A CANCER IMMUNOTHERAPY AGENT AND RELATED USE |
| TW202305006A (zh) | 2021-05-07 | 2023-02-01 | 南韓商益免安協公司 | 與ｃｄ４７及ｐｄ—ｌ１特異性結合的雙特異性抗體 |
| CN117916264A (zh) | 2021-06-09 | 2024-04-19 | 索伦托药业有限公司 | 通过经由淋巴微针递送装置施用抗pd-1或抗pd-l1治疗剂来治疗癌症的方法 |
| CN119866227A (zh) * | 2022-09-19 | 2025-04-22 | 索诺玛生物治疗公司 | 用于靶向调节性t细胞以治疗化脓性汗腺炎的瓜氨酸化抗原特异性嵌合抗原受体 |
| JP2026504180A (ja) | 2023-01-30 | 2026-02-03 | カイマブ・リミテッド | 抗体 |
| WO2025183487A1 (en) * | 2024-02-29 | 2025-09-04 | Yuhan Corporation | Anti-tigit/anti-pd-l1 bispecific antibody and use thereof |
| KR20250165706A (ko) | 2024-04-13 | 2025-11-27 | 주식회사 이뮨온시아 | 암 치료를 위한 pd-l1 저해제를 이용한 신보조요법 |
| EP4656658A1 (en) | 2024-04-13 | 2025-12-03 | Immuneoncia Therapeutics, Inc. | Neoadjuvant therapy using pd-l1 inhibitor for treating cancer |
Family Cites Families (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| US3901654A (en) | 1971-06-21 | 1975-08-26 | Biological Developments | Receptor assays of biologically active compounds employing biologically specific receptors |
| US3817827A (en) | 1972-03-30 | 1974-06-18 | Scott Paper Co | Soft absorbent fibrous webs containing elastomeric bonding material and formed by creping and embossing |
| US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| US4002531A (en) | 1976-01-22 | 1977-01-11 | Pierce Chemical Company | Modifying enzymes with polyethylene glycol and product produced thereby |
| US4098876A (en) | 1976-10-26 | 1978-07-04 | Corning Glass Works | Reverse sandwich immunoassay |
| JPS6023084B2 (ja) | 1979-07-11 | 1985-06-05 | 味の素株式会社 | 代用血液 |
| US4640835A (en) | 1981-10-30 | 1987-02-03 | Nippon Chemiphar Company, Ltd. | Plasminogen activator derivatives |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4496689A (en) | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
| EP0206448B1 (en) | 1985-06-19 | 1990-11-14 | Ajinomoto Co., Inc. | Hemoglobin combined with a poly(alkylene oxide) |
| US4791192A (en) | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US6010902A (en) | 1988-04-04 | 2000-01-04 | Bristol-Meyers Squibb Company | Antibody heteroconjugates and bispecific antibodies for use in regulation of lymphocyte activity |
| US5766897A (en) | 1990-06-21 | 1998-06-16 | Incyte Pharmaceuticals, Inc. | Cysteine-pegylated proteins |
| GB9014932D0 (en) | 1990-07-05 | 1990-08-22 | Celltech Ltd | Recombinant dna product and method |
| JP3051145B2 (ja) | 1990-08-28 | 2000-06-12 | 住友製薬株式会社 | 新規なポリエチレングリコール誘導体修飾ペプチド |
| US5582996A (en) | 1990-12-04 | 1996-12-10 | The Wistar Institute Of Anatomy & Biology | Bifunctional antibodies and method of preparing same |
| DE4118120A1 (de) | 1991-06-03 | 1992-12-10 | Behringwerke Ag | Tetravalente bispezifische rezeptoren, ihre herstellung und verwendung |
| WO1994004679A1 (en) | 1991-06-14 | 1994-03-03 | Genentech, Inc. | Method for making humanized antibodies |
| US5281698A (en) | 1991-07-23 | 1994-01-25 | Cetus Oncology Corporation | Preparation of an activated polymer ester for protein conjugation |
| EP0604580A1 (en) | 1991-09-19 | 1994-07-06 | Genentech, Inc. | EXPRESSION IN E. COLI OF ANTIBODY FRAGMENTS HAVING AT LEAST A CYSTEINE PRESENT AS A FREE THIOL, USE FOR THE PRODUCTION OF BIFUNCTIONAL F(ab') 2? ANTIBODIES |
| JPH05244982A (ja) | 1991-12-06 | 1993-09-24 | Sumitomo Chem Co Ltd | 擬人化ｂ−ｂ１０ |
| NZ255041A (en) | 1992-07-13 | 1996-11-26 | Bionebraska Inc | Preparation of a recombinant single copy polypeptide or portion thereof modified with a terminal alpha amino carbon reactive group and reactive side chain groups involving biologically added protective groups |
| US5382657A (en) | 1992-08-26 | 1995-01-17 | Hoffmann-La Roche Inc. | Peg-interferon conjugates |
| WO1994010308A1 (en) | 1992-10-23 | 1994-05-11 | Immunex Corporation | Methods of preparing soluble, oligomeric proteins |
| US5446090A (en) | 1993-11-12 | 1995-08-29 | Shearwater Polymers, Inc. | Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules |
| US5824784A (en) | 1994-10-12 | 1998-10-20 | Amgen Inc. | N-terminally chemically modified protein compositions and methods |
| US5789199A (en) | 1994-11-03 | 1998-08-04 | Genentech, Inc. | Process for bacterial production of polypeptides |
| US5932462A (en) | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| US5840523A (en) | 1995-03-01 | 1998-11-24 | Genetech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
| GB9722131D0 (en) | 1997-10-20 | 1997-12-17 | Medical Res Council | Method |
| US20020142374A1 (en) | 1998-08-17 | 2002-10-03 | Michael Gallo | Generation of modified molecules with increased serum half-lives |
| GB9928787D0 (en) | 1999-12-03 | 2000-02-02 | Medical Res Council | Direct screening method |
| US6938003B2 (en) | 2000-06-30 | 2005-08-30 | Mahesh Harpale | Method and apparatus for a credibility reporting system to augment an online exchange |
| WO2002026265A2 (en) | 2000-09-29 | 2002-04-04 | Schering Corporation | Pegylated interleukin-10 |
| GB0025144D0 (en) | 2000-10-13 | 2000-11-29 | Medical Res Council | Concatenated nucleic acid sequences |
| US20040202995A1 (en) | 2003-04-09 | 2004-10-14 | Domantis | Nucleic acids, proteins, and screening methods |
| US7902338B2 (en) * | 2003-07-31 | 2011-03-08 | Immunomedics, Inc. | Anti-CD19 antibodies |
| DK2162149T3 (da) | 2007-06-01 | 2014-02-10 | Jackson H M Found Military Med | Vaccine til forebyggelse af brystkræfttilbagefald |
| US8877688B2 (en) * | 2007-09-14 | 2014-11-04 | Adimab, Llc | Rationally designed, synthetic antibody libraries and uses therefor |
| CN104736168B (zh) * | 2012-05-31 | 2018-09-21 | 索伦托治疗有限公司 | 与pd-l1结合的抗原结合蛋白 |
| CA2886433C (en) * | 2012-10-04 | 2022-01-04 | Dana-Farber Cancer Institute, Inc. | Human monoclonal anti-pd-l1 antibodies and methods of use |
| AR093984A1 (es) * | 2012-12-21 | 2015-07-01 | Merck Sharp & Dohme | Anticuerpos que se unen a ligando 1 de muerte programada (pd-l1) humano |
| US9676853B2 (en) * | 2013-05-31 | 2017-06-13 | Sorrento Therapeutics, Inc. | Antigen binding proteins that bind PD-1 |
| EP3126826B1 (en) | 2014-04-04 | 2020-12-16 | Mayo Foundation for Medical Education and Research | Isotyping immunoglobulins using accurate molecular mass |
| CN105238762A (zh) * | 2015-10-26 | 2016-01-13 | 无锡傲锐东源生物科技有限公司 | 抗pd-1蛋白单克隆抗体杂交瘤细胞及其产生的抗pd-1单克隆抗体和应用 |
| CA3013051A1 (en) * | 2016-01-29 | 2017-08-03 | Heyue Zhou | Antigen binding proteins that bind pd-l1 |
-
2017
- 2017-01-27 CA CA3013051A patent/CA3013051A1/en active Pending
- 2017-01-27 AU AU2017212717A patent/AU2017212717B2/en active Active
- 2017-01-27 US US15/418,514 patent/US10118963B2/en active Active
- 2017-01-27 SG SG11201806496SA patent/SG11201806496SA/en unknown
- 2017-01-27 CN CN201780021396.XA patent/CN109715821B/zh active Active
- 2017-01-27 EP EP17745008.7A patent/EP3408400B1/en active Active
- 2017-01-27 JP JP2018559164A patent/JP6883590B2/ja active Active
- 2017-01-27 EA EA201891709A patent/EA037855B1/ru unknown
- 2017-01-27 CN CN202210999239.9A patent/CN116333124A/zh active Pending
- 2017-01-27 WO PCT/US2017/015429 patent/WO2017132562A1/en not_active Ceased
- 2017-01-27 KR KR1020187024978A patent/KR102927822B1/ko active Active
- 2017-01-27 MX MX2018009228A patent/MX2018009228A/es unknown
- 2017-01-27 BR BR112018015480-6A patent/BR112018015480A2/pt not_active Application Discontinuation
- 2017-01-27 ES ES17745008T patent/ES2986360T3/es active Active
- 2017-02-02 TW TW106103519A patent/TWI760323B/zh active
-
2018
- 2018-07-27 MX MX2022011659A patent/MX2022011659A/es unknown
- 2018-07-27 CL CL2018002034A patent/CL2018002034A1/es unknown
- 2018-07-29 IL IL260846A patent/IL260846B2/en unknown
- 2018-07-30 PH PH12018501611A patent/PH12018501611A1/en unknown
- 2018-10-10 US US16/156,895 patent/US10919964B2/en active Active
-
2021
- 2021-01-13 US US17/148,450 patent/US11919952B2/en active Active
- 2021-03-22 JP JP2021047470A patent/JP7140867B2/ja active Active
-
2022
- 2022-04-15 JP JP2022067548A patent/JP2022095910A/ja active Pending
-
2024
- 2024-01-12 US US18/412,102 patent/US20240190959A1/en active Pending